although one of my patients was ataxic for fortyeight hours after each attack. Nystagmus is common. Pallor, sweating and vomiting occur occasionally. The onset is between 2 and 4 years in a normal child with no hearing defect or detectable ear disease, a normal EEG but abnormal caloric tests (canal paresis). This is a benign condition, apparently due to a peripheral nerve lesion of unknown cause, which disappears usually by 5 years of age with no apparent sequelk. Infantile masturbation: This seems to be rare today, or at least it is rare in my experience for an infant who is practising masturbation to be brought for diagnosis. Yet Still in 1910 discussed 39 cases of his own. Thirty-one were girls. The youngest started at 5 months of age. I recently saw a boy aged 9 months referred as a possible case of infantile spasms. For about six weeks he had had episodes when sitting down (and only when sitting); he would wave his arms about synchronously, gripping his fists tightly and working to a crescendo. His eyes were open and staring and it was difficult but not impossible to abort one by talking to him. His legs were lifted slightly extended at the knees, slightly abducted and he swayed slightly backwards on his bottom. It lasted up to five seconds and then he would go pale and continue with what he was doing. Although there might be a series of them the gap between two successive ones was never less than five minutes. His intelligent mother said 'At first I thought it was boredom. They are nasty to watch.' On examination no abnormality was found and in particular his developmental progress and status were normal for his age. I had little doubt that this was infantile masturbation but had an EEG done to make surethis was normal. They stopped when he started to become mobile.
In the second or third year of life paramasturbatory or 'gratification phenomena' can occur and may cause confusion. When excited by a pleasurable event or its anticipation, the child tenses his muscles (often his hands and arms, which shake) and may jog up and down, the face flushes and he may mumble a word or two. If he can be induced to talk about them he may call them 'my dreams' or describe an obviously pleasurable sensation. Their description by a parent may cause some puzzlement. But if the physician sees one himself there is usually little difficulty in making the diagnosis; it is obviously a pleasurable event or the expression of pleasure.
Pallid syncope, paroxysmal vertigo, infantile masturbation and gratification phenomena are poorly described in the standard texts. They are uncommon but diagnosis is important in order to prevent a label of a convulsive disorder being attached to the child.
Dr EM Brett (Hospitalfor Sick Children, Great Ormond Street, London WCIN3JH)
Treatment of Febrile Convulsions
It has long been known that certain otherwise normal children between the ages of 1 and 6 years (with some spread at either end of this span) may have convulsions, during the common febrile illnesses of childhood, but not otherwise. The term febrile convulsions is traditionally used for these attacks. It seems preferable to exclude from this category children with recurrent seizures of which only a minority occur with fever. Boys outnumber girls, and close relatives (siblings, a parent or grandparent) often show a similar tendency to convulse with fever. This tendency, which seems to be genetically determined, ceases in most patients as they reach the age of 5, 6 or 7 years. Most children are probably none the worse for the attacks, which are brief and last under ten minutes, but some last long enough to constitute status epilepticus (defined as continuous convulsions lasting thirty minutes or more).
The problem is common: the mean incidence was 29/1000 children under 5 years in six large populations studied (Lennox-Buchthal 1973) . Some authors, as in a recent editorial (British Medical Journal 1972) , apply rigid criteria for the definition of febrile convulsions. They exclude convulsions occurring under 6 months or over 6 years of age, cases without an obvious rapid rise of temperature or clinically obvious illness before the fit, those in which a second fit occurred during the same infection andmore importantthose in which the fit lasted more than ten minutes, was focal or was followed by post-ictal weakness.
I believe that to apply such rigidly exclusive \ riteria is illogical and undesirable. Exceptions to alll these criteria abound, sometimes within a :;ibship and sometimes in the same child from time to time. To take only one example, of 142 children with febrile convulsions admitted to the Royal Alexandra Hospital Brighton in 1972, 23 % had two convulsions in the same febrile episode, and 7 % had three or more (Gilsenan, personal communication).
Section ofPadiatrics
Complications of febrile convulsions have long been known to occur in some cases. Earlier writers estimated that some 5 % of children with febrile convulsions developed recurrent unprovoked seizures in later life and became, by definition, 'epileptic'. The work of Ounsted et al. (1966) has shown the importance of febrile convulsions in the etiology of childhood temporal lobe epilepsy. Falconer and others (Falconer & Taylor 1968 , Falconer 1971 ) have demonstrated that mesial temporal sclerosis is the lesion responsible in such cases, and that surgery can benefit selected patients in this group. The important practical implication to emerge from the collaboration between physician, neurosurgeon and pathologist is that febrile convulsions are potentially harmful and must be stopped as soon as possible. Ounsted's (1971) analysis of 438 children with febrile convulsions showed that 33 convulsed to death (22 boys and 11 girls) and 120 suffered further attacks. There is convincing evidence that the attacks should be terminated promptly and prevented if possible, but the question is how.
The immediate problem of stopping the convulsion usually confronts the family doctor who is thus a key figure. Advice to send the child to hospital without trying to stop the fit is unacceptable. Antipyretic measures, such as sponging, fanning and aspirin, are important. Parents must be taught not to wrap a febrile child up in blankets. The choice of injectable agents depends on the situation. Intramuscular paraldehyde, though an old-fashioned remedy, is still useful and safe (plastic syringes should not be used). It may also be given rectally. Diazepam is an excellent drug. Respiratory or cardiac arrest may occur with it, especially if used after barbiturates or paraldehyde. It has been suggested that it should only be used intravenously when resuscitation facilities exist.
When a child has had a febrile convulsion a decision must be made whether to use anticonvulsants or not. Their intermittent use is often ineffective since most children give insufficient warning of infection to allow adequate blood levels to be reached in time. However, recent work in Stockholm (Jalling, personal communication 1973) has shown that single, very high doses of phenobarbitone, given orally or intramuscularly, produced within four hours plasma levels in the range found to be effective in the long term prevention of febrile convulsions. These preliminary results suggest that in selected cases the attacks might be prevented by intermittent phenobarbitone.
In the long-term preventive treatment of febrile convulsions, phenytoin and phenobarbitone have been most often used. Phenytoin has given disappointing results (Millichap et al. 1960 , Melchior et al. 1971 ). Melchior and his colleagues found that it did not prevent further attacks in children under 3 years despite serum levels in the therapeutic range. However, the treated patients seemed to be protected from severe convulsions. In children with age of onset over 3, phenytoin was more successful, but this age-group may be less vulnerable.
Phenobarbitone seems more promising. A collaborative Danish study (Faer0 et al. 1972) showed that it was effective only if serum concentrations were kept over 16 mg/l. This is encouraging, but many young children tolerate phenobarbitone badly, and irritable and difficult behaviour may demand its withdrawal. It has been suggested that all children who have had a febrile convulsion should take the drug regularly for some years. Estimates of the numbers of children involved in the United Kingdom in 1973 vary from 114000-190000, a formidable total to be treated.
Probably over half of affected children will have only one febrile convulsion. If these children could be picked out, treatment could be limited. Evidence on the risk of recurrence after one febrile convulsion is accumulating from different sources, but is somewhat conflicting. Analysis of the Danish results (Lennox-Buchthal 1973) suggested that age of onset was the most important factor. Half the children under 14 months had a further attack, compared with only 120% whose onset was after 3 years. Female sex and having a relative with febrile convulsions greatly increased the risk of further attacks. The risk that a further attack would be severe appeared to depend similarly on age and sex, but also on the number of febrile convulsions, increasing with each new convulsion.
Wallace (1974) in her study of 116 children untreated and 73 selectively treated after their first attack, did not find sex to be statistically significant for recurrence. A family history of any convulsive disorder in siblings and/or parents seemed significant in males, but not in females. Her most striking finding was the positive correlation between recurrence and a prolonged (at least thirty minutes) or repeated initial seizure, and a persisting neurological disorder, even minimal, after the initial illness had subsided. She found an impressive reduction in the recurrence rate in the treated children with a complicated or repeated initial seizure compared with the untreated, from 60-13 %.
The urgent need to control febrile convulsions must be impressed on all who are concerned with young children. The factors influencing the risk of recurrence and of severe future fits need to be more clearly defined in order to identify for prophylactic treatment those children most at risk. Each case needs to be carefully assessed in the light of studies such as those described to decide whether or not anticonvulsants (and which anticonvulsant) should be started. In the management of the individual child, and in the collection of epidemiological data of more conclusive value progress requires closer cooperation between hospital, community and family doctors.
Dr A T Roden (Department ofHealth and Social Security, Alexander Fleming House, London SEI) It is difficult to get to grips with the problem of fits following immunization. Information is often incomplete, both quantitatively and qualitatively and it is often difficult to know how much clinical significance to attach to it. Estimates of the incidence of vaccine-associated convulsive disorders vary with sources of information. The most precise estimates are likely to be obtained from controlled field trials of vaccines, such as the Medical Research Council's trials of whoopingcough vaccine and of measles vaccine. This source suffers from two inescapable limitations: (1) Those who volunteer and are accepted for trials of vaccines are not necessarily representative of the community as a whole and may not contain groups at special risk of adverse effects. (2) Even large trials may fail to detect rare complications, some of which may prove to have serious clinical significance.
Attempts to derive information on a national scale suffer from incomplete reporting. About six months before the national campaign for vaccination against measles was launched the Committee on Safety of Drugs (as it then was) drew the attention of doctors to the importance of reporting adverse reactions to vaccines and other immunological agents, including hyperpyrexia, meningism, prolonged drowsiness and convulsions. A subsequent analysis of the reports received showed an incidence of convulsions of a little over 19/100 000 after measles vaccination of children under the age of 2 years, in contrast to an incidence of 19/10 000 observed in the Medical Research Council's clinical trial.
Reports may also be qualitatively incomplete, especially as regards the all-important time interval between the immunization and the onset of illness, and also other relevant details such as the manufacturer and batch number of the product. Investigations to establish possible causative factors are often inadequate. Nevertheless, information of some value can be derived from this reporting system (Pan American Health Organization 1971).
Even with adequate reporting, the interpretation of the data derived may yet prove difficult. In the individual case it may be impossible to decide whether the illness was caused or precipitated by the immunizing procedure or was purely coincidental. Statistical analysis of accumulated data, especially as regards timeintervals, is usually necessary to demonstrate a causative association.
There seems little doubt that any immunizing procedure that may give rise to a marked febrile reaction will precipitate a convulsion in a proportion of children, mainly under the age of 3 years, and in older persons prone to convulsive states. It is not always clear what the clinical significance of a febrile convulsion may be in a child who has previously shown no evidence of disorder of the central nervous system. Is there any way of determining beforehand those children who are likely to come to permanent harm as a result of a febrile convulsion? REFERENCE Pan American Health Organization (I1971) Proceedings of an International Conference on the Application of Vaccines against Viral, Rickettsial and Bacterial Diseases of Man, 1970, pp 447-448 The following papers were also read: 
DPT Encephalopathy

